LINC00643: A Potential Drug Target and Biomarker (G646113)

Target Name: LINC00643

NCBI ID: G646113

LINC00643

Other Name(s): SERTA domain containing 4B, pseudogene | long intergenic non-protein coding RNA 643 | Long intergenic non-protein coding RNA 643 | SERTAD4BP

LINC00643: A Potential Drug Target and Biomarker

LINC00643 is a non-coding RNA molecule located in the SERTA domain of the human chromosome 1p36.13. It is a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The SERTA domain is a conserved region that is found in the protein-coding regions of many genomes. It is involved in the regulation of gene expression and has been implicated in various cellular processes, including cell adhesion, migration, and signaling pathways. The SERTA domain has also been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Potential Drug Target

LINC00643 is a potential drug target because of its involvement in various cellular processes that are linked to the development and progression of diseases. For example, LINC00643 has been shown to be involved in the regulation of cell adhesion, which is a critical process for the development of cancer.

In addition, LINC00643 has been shown to be involved in the regulation of the Notch signaling pathway, which is a critical pathway for the development and progression of neurodegenerative diseases. The Notch signaling pathway is involved in the regulation of cell survival and has been implicated in the development of various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Potential Biomarker

LINC00643 may also be a potential biomarker for various diseases. For example, LINC00643 has been shown to be expressed in various tissues and cells, including brain, spleen, and peripheral blood cells. This suggests that it may be a useful biomarker for diseases that affect these tissues, such as cancer, neurodegenerative diseases, and autoimmune disorders.

In addition, LINC00643 has been shown to be involved in the regulation of various cellular processes that are linked to the development and progression of diseases. For example, LINC00643 has been shown to be involved in the regulation of cell apoptosis, which is a critical process for the regulation of cell numbers and the elimination of damaged or dysfunctional cells.

Conclusion

In conclusion, LINC00643 is a potential drug target and biomarker for various diseases. Its involvement in the regulation of cell adhesion, the Notch signaling pathway, and the regulation of cell apoptosis makes it a promising candidate for drug development. Further research is needed to determine its utility as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 643

The "LINC00643 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00643 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets